Monetizing Chronic Illness in America - Exposing Corruption in American Healthcare

This interview discusses the alleged corruption within the American healthcare system, focusing on the significant influence and profit-driven practices of large insurance companies and pharmacy benefit managers (PBMs). The speaker details how PBMs, owned by major insurers, inflate drug prices and obstruct access to affordable care, contributing to the opioid crisis and the high cost of chronic disease treatment. The interview also touches upon the roles of the FDA and pharmaceutical companies in exacerbating these issues, and explores alternative healthcare models prioritizing preventative care. Finally, the interview mentions potential solutions, including government intervention and a shift towards patient-centered, cash-based healthcare.